Back to School: How biopharma can reboot drug development. Access exclusive analysis here

1016 Friday NASDAQ listings
BioCentury & Getty Images

Finance

Praxis sees strongest first-day among trio of IPOs as NASDAQ nears $16B raised in fresh paper

Oct 17, 2020 | 1:25 AM GMT

Among a trio of clinical biotechs pricing IPOs ahead of Friday’s NASDAQ session, demand was highest for Praxis as the company posted a 46%

Read the full 538 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE